CRISPR-Cas antimicrobials: Challenges and future prospects

PLoS Pathog. 2018 Jun 14;14(6):e1006990. doi: 10.1371/journal.ppat.1006990. eCollection 2018 Jun.

Authors

Elizabeth Pursey^{1

2}, David Sünderhauf^{1

2}, William H Gaze², Edze R Westra¹, Stineke van Houte¹

Affiliations

¹ Environment and Sustainability Institute, Centre for Ecology and Conservation, University of Exeter, Biosciences, Penryn, Cornwall, United Kingdom.
² European Centre for Environment and Human Health, University of Exeter Medical School, Knowledge Spa, Royal Cornwall Hospital, Truro, Cornwall, United Kingdom.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-Infective Agents / pharmacology*
Bacteria / drug effects*
Bacteria / genetics
CRISPR-Cas Systems*
Gene Editing*
Gene Expression Regulation, Bacterial / drug effects*
Genetic Engineering
Microbial Viability / drug effects*
Transformation, Bacterial

Substances

Anti-Infective Agents

Grants and funding